Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia.

Schizophrenia research - 1 Jan 2016

Malan-Müller Stefanie, Kilian Sanja, van den Heuvel Leigh L, Bardien Soraya, Asmal Laila, Warnich Louise, Emsley Robin A, Hemmings Sîan M J, Seedat Soraya

Abstract excerpt

Metabolic syndrome (MetS) is a cluster of factors that increases the risk of cardiovascular disease (CVD), one of the leading causes of mortality in patients with schizophrenia. Incidence rates of MetS are significantly higher in patients with schizophrenia compared to the general population. Several factors contribute to this high comorbidity. This systematic review focuses on genetic factors and interrogates...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to FTO gene
Share to LEP gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to LEPR gene

Share to MTHFR gene

Share to Genetic Variation

Share to Metabolic Syndrome

Share to Schizophrenia

Source

Identifiers

PMID: 26621002
DOI: 10.1016/j.schres.2015.11.011

Genes

FTO
LEP
LEPR
MTHFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia.PMID 26621002Read ↗

Genetic predisposition and antipsychotic treatment effect on metabolic syndrome in schizophrenia: a ten-year follow-up study using the Estonian BiobankSemantic proximity Read ↗

Prevalence and factors associated of metabolic syndrome in first- treatment drug-naïve schizophrenia patients: a large-scale cross- sectional studySemantic proximity Read ↗

Genome-wide associations with metabolic syndrome among UK Biobank participants reporting use of second-generation antipsychotics.Semantic proximity Read ↗

Gene Polymorphisms of Hormonal Regulators of Metabolism in Patients with Schizophrenia with Metabolic Syndrome.Semantic proximity Read ↗

Genome Wide Association Study (GWAS) Identifies Novel Genetic Loci for Second-Generation Antipsychotics (SGA)-Induced Metabolic Syndrome (MetS).Semantic proximity Read ↗

CNR1 gene and risk of the metabolic syndrome in patients with schizophrenia.Semantic proximity Read ↗

The Multidimensional Nature of Metabolic Syndrome in Schizophrenia: Lessons from Studies of One-Carbon Metabolism and DNA MethylationSemantic proximity Read ↗

NOS1AP Gene Variants and Their Role in Metabolic Syndrome: A Study of Patients with SchizophreniaSemantic proximity Read ↗

Gender differences in prevalence and associated factors of metabolic syndrome in first-treatment and drug-naïve schizophrenia patientsSemantic proximity Read ↗

Association of FTO, LEPR and MTHFR gene polymorphisms with metabolic syndrome in schizophrenia patients receiving antipsychotics.Semantic proximity Read ↗

Genetic variants of increased waist circumference in psychosis.Semantic proximity Read ↗

Cross-population validation of European GWAS loci for metabolic syndrome in Chinese schizophrenia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.